Is PCOS an inflammatory process?

Atherosclerosis--an inflammatory disease

Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725 · see citing works

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome

(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050 · see citing works

Polycystic Ovary Syndrome

Franks, S. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509283331307 · Cited by 2,463 · see citing works

C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events: An 8-Year Follow-Up of 14 719 Initially Healthy American Women

Ridker, P. M., Buring, J. E., Cook, N. R., & Rifai, N. (2003) · Circulation · doi:10.1161/01.cir.0000055014.62083.05 · Cited by 2,292 · see citing works

Men at risk: occupation and male infertility.

Claman, P. (2004) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01188-9 · Cited by 2,219 · see citing works

SEROLOGICAL EVIDENCE OF AN ASSOCIATION OF A NOVEL CHLAMYDIA, TWAR, WITH CHRONIC CORONARY HEART DISEASE AND ACUTE MYOCARDIAL INFARCTION

Saikku, P., Mattila, K. J., Nieminen, M. S., Huttunen, J. K., Leinonen, M., Ekman, M.-R., Mäkelä, P. H., & Valtonen, V. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90741-6 · Cited by 1,961 · see citing works

Interleukin‐6 is the major regulator of acute phase protein synthesis in adult human hepatocytes

Castell, J. V., Gómez-Lechón, M. J., David, M., Andus, T., Geiger, T., Trullenque, R., Fabra, R., & Heinrich, P. C. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)80476-4 · Cited by 893 · see citing works

Low grade chronic inflammation in women with polycystic ovarian syndrome

Kelly, C. C. J., Lyall, H., Petrie, J. R., Gould, G. W., Connell, J. M. C., & Sattar, N. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.6.7580 · Cited by 640 · see citing works

C-Reactive Protein and the Prediction of Cardiovascular Events Among Those at Intermediate Risk

Ridker, P. M. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.02.052 · Cited by 622 · see citing works

Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis

Escobar-Morreale, H. F., Luque‐Ramírez, M., & González, F. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.11.036 · Cited by 522 · see citing works

Oxidative stress and endothelial dysfunction in hypertension

Schulz, E., Gori, T., & Münzel, T. F. (2011) · Hypertension Research · doi:10.1038/hr.2011.39 · Cited by 503 · see citing works

Polycystic Ovary Syndrome Is Associated With Endothelial Dysfunction

Paradisi, G., Steinberg, H. O., Hempfling, A., Cronin, J., Brechtel, G., Shepard, M. K., & Baron, A. (2001) · Circulation · doi:10.1161/01.cir.103.10.1410 · Cited by 476 · see citing works

Reactive Oxygen Species-Induced Oxidative Stress in the Development of Insulin Resistance and Hyperandrogenism in Polycystic Ovary Syndrome

González, F., Rote, N. S., Minium, J., & Kirwan, J. P. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1696 · Cited by 459 · see citing works

Early Impairment of Endothelial Structure and Function in Young Normal-Weight Women with Polycystic Ovary Syndrome

Orio, F., Palomba, S., Cascella, T., Simone, B. D., Biase, S. D., Russo, T., Labella, D., Zullo, F., Lombardi, G., & Colao, A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031867 · Cited by 330 · see citing works

Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease☆

Sabuncu, T., Vural, H., Harma, M., & Harma, M. I. (2001) · Clinical Biochemistry · doi:10.1016/s0009-9120(01)00245-4 · Cited by 330 · see citing works

Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance

Carmina, E., Bucchieri, S., Esposito, A., Del Puente, A., Mansueto, P., Orio, F., Di Fede, G., & Rini, G. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2725 · Cited by 317 · see citing works

Decreased total antioxidant status and increased oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease

Fenkçi, V., Fenkçi, S. M., Yılmazer, M., & Serteser, M. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(03)00571-5 · Cited by 306 · see citing works

Infections, Immunity, and Atherosclerosis

Mayr, M., Kiechl, S. J., Willeit, J., Wick, G., & Xu, Q. (2000) · Circulation · doi:10.1161/01.cir.102.8.833 · Cited by 297 · see citing works

Endothelial Dysfunction in Young Women with Polycystic Ovary Syndrome: Relationship with Insulin Resistance and Low-Grade Chronic Inflammation

Tarkun, İ., ARSLAN, B., Cantürk, Z., Türemen, E., Şahı̇n, T., & Duman, C. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0751 · Cited by 297 · see citing works

Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications

Niu, J., & Kolattukudy, P. E. (2009) · Clinical Science · doi:10.1042/cs20080581 · Cited by 292 · see citing works

The vicious circle between oxidative stress and inflammation in atherosclerosis

Hulsmans, M., & Holvoet, P. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00978.x · Cited by 271 · see citing works

Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis

Toulis, K. A., Goulis, D. G., Farmakiotis, D., Georgopoulos, N. A., Katsikis, I., Tarlatzis, B. C., Papadimas, I., & Panidis, D. (2009) · Human Reproduction Update · doi:10.1093/humupd/dmp006 · Cited by 262 · see citing works

The Increase of Leukocytes as a New Putative Marker of Low-Grade Chronic Inflammation and Early Cardiovascular Risk in Polycystic Ovary Syndrome

Orio, F., Palomba, S., Cascella, T., Biase, S. D., Manguso, F., Tauchmanovà, L., Nardo, L. G., Labella, D., Savastano, S., Russo, T., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0628 · Cited by 257 · see citing works

White blood cell count

Brown, D. W., Giles, W. H., & Croft, J. B. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00296-1 · Cited by 241 · see citing works

Serum Interleukin-18 Concentrations Are Increased in the Polycystic Ovary Syndrome: Relationship to Insulin Resistance and to Obesity

Escobar-Morreale, H. F., Botella-Carretero, J. I., Villuendas, G., Sancho, J., & Millán, J. L. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031365 · Cited by 199 · see citing works

Endothelial Dysfunction in PCOS: Role of Obesity and Adipose Hormones

Carmina, E., Orio, F., Palomba, S., Longo, R. A., Cascella, T., Colao, A. A. L., Lombardi, G., Rini, G. B., & Løbo, R. A. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.10.059 · Cited by 199 · see citing works

Young Obese Women with Polycystic Ovary Syndrome Have Evidence of Early Coronary Atherosclerosis

Juran, R., Kerchner, A., Maifeld, M., van Beek, E. J. R., Jagasia, D. H., & Dokras, A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1343 · Cited by 194 · see citing works

C-Reactive Protein Promotes Monocyte Chemoattractant Protein-1–Mediated Chemotaxis Through Upregulating CC Chemokine Receptor 2 Expression in Human Monocytes

Han, K.-H., Hong, K.-H., Park, J.-H., Ko, J., Kang, D., Choi, K.-J., Hong, M., Park, S.-W., & Park, S.-J. (2004) · Circulation · doi:10.1161/01.cir.0000131160.94926.6e · Cited by 193 · see citing works

Polycystic Ovary Syndrome

Nandi, A. A., Chen, Z., Patel, R., & Poretsky, L. (2014) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.10.003 · Cited by 189 · see citing works

Metformin administration improves endothelial function in women with polycystic ovary syndrome

Diamanti‐Kandarakis, E., Alexandraki, K., Protogerou, A. D., Piperi, C., Papamichael, C. M., Aessopos, A., Lekakis, J., & Mavrikakis, M. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01910 · Cited by 179 · see citing works

Increased serum advanced glycation end‐products is a distinct finding in lean women with polycystic ovary syndrome (PCOS)

Diamanti‐Kandarakis, E., Katsikis, I., Piperi, C., Kandaraki, E., Piouka, A., Papavassiliou, A. G., & Panidis, D. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03247.x · Cited by 172 · see citing works

Inflammatory and endothelial markers in women with polycystic ovary syndrome

Diamanti‐Kandarakis, E., Alexandraki, K., Piperi, C., Protogerou, A. D., Katsikis, I., Paterakis, T., Lekakis, J., & Panidis, D. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01712.x · Cited by 168 · see citing works

Effect of C-reactive protein on vascular cells: evidence for a proinflammatory, proatherogenic role

Venugopal, S. K., Devaraj, S., & Jialal, I. (2004) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200501000-00006 · Cited by 155 · see citing works

Clinical Significance of Inflammatory Markers in Polycystic Ovary Syndrome: Their Relationship to Insulin Resistance and Body Mass Index

Samy, N., Hashim, M., Sayed, M., & Said, M. (2009) · Disease Markers · doi:10.1155/2009/465203 · Cited by 142 · see citing works

Evidence of proatherogenic inflammation in polycystic ovary syndrome

González, F., Rote, N. S., Minium, J., & Kirwan, J. P. (2009) · Metabolism · doi:10.1016/j.metabol.2009.02.022 · Cited by 135 · see citing works

Oxidative stress but not endothelial dysfunction exists in non‐obese, young group of patients with polycystic ovary syndrome

Kuşçu, N. K., & Var, A. (2009) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1080/00016340902859315 · Cited by 125 · see citing works

Clinical significance of inflammatory markers in polycystic ovary syndrome: their relationship to insulin resistance and body mass index.

Samy, N., Hashim, M., Sayed, M., et al. (2009) · PubMed · doi:10.3233/dma-2009-0627 · Cited by 117 · see citing works

Plasma interleukin 6 levels are elevated in polycystic ovary syndrome independently of obesity or sleep apnea

Vgontzas, A. N., Trakada, G., Bixler, E. O., Lin, H.-M., Pejovic, S., Zoumakis, E., Chrousos, G. P., & Legro, R. S. (2006) · Metabolism · doi:10.1016/j.metabol.2006.04.002 · Cited by 114 · see citing works

Interleukin-18, the Metabolic Syndrome, and Subclinical Atherosclerosis

Zirlik, A., Abdullah, S. M., Gerdes, N., MacFarlane, L. A., Schönbeck, U., Khera, A., McGuire, D. K., Vega, G. L., Grundy, S. M., Libby, P., et al. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.149484 · Cited by 113 · see citing works

DNA damage, DNA susceptibility to oxidation and glutathione level in women with polycystic ovary syndrome

̇ncer, Y. D., Akçay, T., Yesim, T. E., Saygılı, E. İ., & Gündoğdu, S. (2005) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510500375263 · Cited by 95 · see citing works

Association between Circulating Tumor Necrosis Factor-Alpha, Interleukin-6, and Insulin Resistance in Normal-Weight Women with Polycystic Ovary Syndrome

Tarkun, İ., Çetinarslan, B., Türemen, E., Cantürk, Z., & Biyikli, M. (2006) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2006.4.122 · Cited by 93 · see citing works

Body Size Phenotypes and Inflammation in the Women's Health Initiative Observational Study

Wildman, R. P., Kaplan, R. C., Manson, J. E., Rajkovic, A., Connelly, S. A., Mackey, R. H., Tinker, L. F., Curb, J. D., Eaton, C. B., & Wassertheil‐Smoller, S. (2011) · Obesity · doi:10.1038/oby.2010.332 · Cited by 84 · see citing works

Prospective association of periodontal disease with cardiovascular and all-cause mortality: NHANES III follow-up study

Xu, F., & Lü, B. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.07.091 · Cited by 81 · see citing works

Abdominal subcutaneous fat gene expression and circulating levels of leptin and adiponectin in polycystic ovary syndrome

Lecke, S. B., Mattei, F. N., Morsch, D. M., & Spritzer, P. M. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.02.041 · Cited by 80 · see citing works

Plasma monocyte chemoattractant protein‐1 (MCP‐1) and macrophage inflammatory protein‐1α are increased in patients with polycystic ovary syndrome (PCOS) and associated with adiposity, but unaffected by pioglitazone treatment

Glintborg, D., Andersen, M., Richelsen, B., & Bruun, J. M. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03523.x · Cited by 78 · see citing works

Periodontal disease in polycystic ovary syndrome

Dursun, E., Akalın, F. A., Güncü, G. N., Çınar, N., Aksoy, D., Tözüm, T. F., Kılınç, K., & Yıldız, B. O. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.07.1052 · Cited by 76 · see citing works

Plasma interleukin-18 levels are increased in the polycystic ovary syndrome: relationship of carotid intima-media wall thickness and cardiovascular risk factors

Kaya, C., Pabuçcu, R., Berker, B., & Şatıroğlu, H. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.10.070 · Cited by 74 · see citing works

Proteomic Analysis of Plasma in the Polycystic Ovary Syndrome Identifies Novel Markers Involved in Iron Metabolism, Acute-Phase Response, and Inflammation

Insenser, M. R., Martínez-García, M. Á., Montes, R., San‐Millán, J. L., & Escobar-Morreale, H. F. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0220 · Cited by 71 · see citing works

CCL3 (MIP-1α) levels are elevated during acute coronary syndromes and show strong prognostic power for future ischemic events

de Jager, S. C. A., Kraaijeveld, A. O., Grauss, R. W., de Jager, W., Liem, S., van der Hoeven, B. L., Prakken, B. J., Putter, H., van Berkel, T. J. C., Atsma, D. E., et al. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.06.003 · Cited by 70 · see citing works

Anti-mullerian hormone is associated with advanced glycosylated end products in lean women with polycystic ovary syndrome

Diamanti‐Kandarakis, E., Piouka, A., Livadas, S., Piperi, C., Katsikis, I., Papavassiliou, A. G., & Panidis, D. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0510 · Cited by 66 · see citing works

Is interleukin-18 associated with polycystic ovary syndrome?

Yan, Y., Qiao, J., Li, R., & Li, M. (2011) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-9-7 · Cited by 66 · see citing works

High mean platelet volume, low-grade systemic coagulation and fibrinolytic activation are associated with androgen and insulin levels in polycystic ovary syndrome

Kebapçılar, L., Taner, C. E., Kebapçılar, A. G., & Sarı, İ. (2008) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-008-0884-0 · Cited by 65 · see citing works

Polycystic ovarian syndrome and subclinical atherosclerosis among women of reproductive age in the Dallas heart study

Chang, A. Y., Ayers, C. R., Minhajuddin, A., Jain, T., Nurenberg, P., de Lemos, J. A., Wild, R. A., & Auchus, R. J. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03907.x · Cited by 64 · see citing works

A comprehensive assessment of endothelial function in overweight women with and without polycystic ovary syndrome

Moran, L. J., Hutchison, S. K., Meyer, C., Zoungas, S., & Teede, H. J. (2009) · Clinical Science · doi:10.1042/cs20080218 · Cited by 59 · see citing works

Elevated C-reactive protein and monocyte chemoattractant protein-1 in patients with polycystic ovary syndrome

Hu, W., Qiao, J., Yan, Y., Wang, L., & Li, R. (2011) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2011.03.015 · Cited by 56 · see citing works

Body fat and insulin resistance independently predict increased serum C-reactive protein in hyperandrogenic women with polycystic ovary syndrome

Tosi, F., Dorizzi, R. M., Castello, R., Maffeis, C., Spiazzi, G., Zoppini, G., Muggeo, M., & Moghetti, P. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0379 · Cited by 56 · see citing works

Polycystic ovary syndrome and the peripheral blood white cell count

Herlihy, A., Kelly, R. E., Hogan, J. L., O’Connor, N., Farah, N., & Turner, M. J. (2011) · Journal of Obstetrics and Gynaecology · doi:10.3109/01443615.2011.553693 · Cited by 52 · see citing works

Elevated Serum Levels of Interleukin-18 Are Associated with Insulin Resistance in Women with Polycystic Ovary Syndrome

Zhang, Y., Yang, Y., Hong, J., Gu, W., Shen, C., Xu, M., Du, P., Li, X.-Y., & Ning, G. (2006) · Endocrine · doi:10.1385/endo:29:3:419 · Cited by 49 · see citing works

WBC Count, Atherosclerosis and Coronary Risk Factors.

Hasegawa, T., Negishi, T., & Deguchi, M. (2002) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.9.219 · Cited by 41 · see citing works

Cardiovascular Disease: What's All the AGE/RAGE About?

Barlovič, D. P., Thomas, M. C., & Jandeleit-Dahm, K. A. M. (2010) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/187152910790780050 · Cited by 40 · see citing works

Interleukin-18: an independent predictor of cardiovascular events in patients with acute coronary syndrome after 6 months of follow-up

Furtado, M. V., Rossini, A. P. W., Campani, R. B., Meotti, C. D., Segatto, M. M., Vietta, G. G., & Polanczyk, C. A. (2009) · Coronary Artery Disease · doi:10.1097/mca.0b013e32832e5c73 · Cited by 37 · see citing works

Helicobacter pylori infection and arterial stiffness in patients with type 2 diabetes mellitus

Ohnishi, M., Fukui, M., Ishikawa, T., Ohnishi, N., Ishigami, N., Yoshioka, K., Hasegawa, G., Yoshikawa, T., & Nakamura, N. (2008) · Metabolism · doi:10.1016/j.metabol.2008.08.001 · Cited by 35 · see citing works

Study on Chronic Low-Grade Inflammation and Influential Factors of Polycystic Ovary Syndrome

Ruan, X., & Dai, Y. (2009) · Medical Principles and Practice · doi:10.1159/000189809 · Cited by 34 · see citing works

A Novel Association Between Polycystic Ovary Syndrome and Helicobacter pylori

Yavaşoğlu, İ., Arslan, E., Küçük, M., Çildağ, B. M., Gok, M., & Kafkas, S. (2009) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181a63c8a · Cited by 26 · see citing works

Chlamydia antibodies and self-reported symptoms of oligo-amenorrhea and hirsutism: A new etiologic factor in polycystic ovary syndrome?

Morin-Papunen, L. C., Dulęba, A. J., Bloigu, A. H., Järvelin, M., Saikku, P., & Pouta, A. M. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.10.021 · Cited by 24 · see citing works

Evidence for increased cardiovascular events in the fathers but not mothers of women with polycystic ovary syndrome

Taylor, M. C., Kar, A. R., Kunselman, A. R., Stetter, C., Dunaif, A. E., & Legro, R. S. (2011) · Human Reproduction · doi:10.1093/humrep/der101 · Cited by 21 · see citing works

Helicobacter pylori seropositivity in patients with unstable angina.

Pellicano, R., Mg, M., Morelloni, S., Ferrari, M., Angelino, P. F., Berrutti, M., Am, T., Rizzetto, M., & Ponzetto, A. (2003) · PubMed · Cited by 17 · see citing works

Plasma concentration of soluble intercellular adhesion molecule-1 in women with polycystic ovary syndrome

Nasiek, M., Kos‐Kudła, B., Ostrowska, Z., Marek, B., Kajdaniuk, D., Siemińśka, L., & Fołtyn, W. (2004) · Gynecological Endocrinology · doi:10.1080/09513590400014313 · Cited by 15 · see citing works

Imaging of Subclinical Atherosclerosis: Questions and Answers

Lin, E. C., Hashimoto, B. E., & Hwang, W. S. (2011) · Current Problems in Diagnostic Radiology · doi:10.1067/j.cpradiol.2010.02.003 · Cited by 5 · see citing works

Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications

Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947 · see citing works

Trends in insulin resistance: insights into mechanisms and therapeutic strategy

Li, M., Chi, X., Wang, Y., Setrerrahmane, S., Xie, W., & Xu, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01073-0 · Cited by 939 · see citing works

Pregnancy complications in women with polycystic ovary syndrome

Palomba, S., de Wilde, M. A., Falbo, A., Koster, M. P. H., La Sala, G. B., & Fauser, B. C. J. M. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmv029 · Cited by 691 · see citing works

Chronic Low Grade Inflammation in Pathogenesis of PCOS

Rudnicka, E., Suchta, K., Grymowicz, M., Calik-Ksepka, A., Smolarczyk, K., Duszewska, A. M., Smolarczyk, R., & Meczekalski, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073789 · Cited by 680 · see citing works

Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth

Rojas, J., Chávez-Castillo, M., Olivar, L. C., Rojas, M., Morillo, J., Mejias, J. A., Calvo, M. C. C., & Bermúdez, V. (2014) · International Journal of Reproductive Medicine · doi:10.1155/2014/719050 · Cited by 485 · see citing works

Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): an update

Gnanadass, S. A., Prabhu, Y. D., & Gopalakrishnan, A. V. (2021) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-020-05951-2 · Cited by 299 · see citing works

Oxidative stress and the ageing endocrine system

Vitale, G., Salvioli, S., & Franceschi, C. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.29 · Cited by 269 · see citing works

Nutrition, inflammation and liver-spleen axis

Barrea, L., Somma, C. D., Muscogiuri, G., Tarantino, G., Tenore, G. C., Orio, F., Colao, A., & Savastano, S. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2017.1353479 · Cited by 304 · see citing works

Polycystic ovary syndrome current status and future perspective

Naz, R. K. (2014) · Frontiers in Bioscience-Elite · doi:10.2741/e695 · Cited by 267 · see citing works

Polycystic ovary syndrome and mitochondrial dysfunction

Zhang, J., Bao, Y.-G., Zhou, X., & Zheng, L. (2019) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-019-0509-4 · Cited by 259 · see citing works

Inflammation and Human Ovarian Follicular Dynamics

Boots, C. E., & Jungheim, E. S. (2015) · Seminars in Reproductive Medicine · doi:10.1055/s-0035-1554928 · Cited by 255 · see citing works

The Role of Chronic Inflammation in Polycystic Ovarian Syndrome—A Systematic Review and Meta-Analysis

Aboeldalyl, S., James, C., Seyam, E., Ibrahim, E. M., Shawki, H., & Amer, S. A. K. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052734 · Cited by 251 · see citing works

Exposure to hyperandrogen drives ovarian dysfunction and fibrosis by activating the NLRP3 inflammasome in mice

Wang, D., Weng, Y., Zhang, Y., Wang, R., Wang, T., Zhou, J., Shen, S., Wang, H., & Wang, Y. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.141049 · Cited by 232 · see citing works

The Role of Inflammation and Inflammatory Mediators in the Development, Progression, Metastasis, and Chemoresistance of Epithelial Ovarian Cancer

Savant, S. S., Sriramkumar, S., & O’Hagan, H. M. (2018) · Cancers · doi:10.3390/cancers10080251 · Cited by 211 · see citing works

The Release of Peripheral Immune Inflammatory Cytokines Promote an Inflammatory Cascade in PCOS Patients via Altering the Follicular Microenvironment

Liu, Y., Liu, H., Li, Z., Fan, H., Yan, X., Liu, X., Xuan, J., Feng, D., & Wei, X. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.685724 · Cited by 190 · see citing works

Depression and Anxiety in Polycystic Ovary Syndrome: Etiology and Treatment

Cooney, L. G., & Dokras, A. (2017) · Current Psychiatry Reports · doi:10.1007/s11920-017-0834-2 · Cited by 173 · see citing works

Inflammatory Markers in Women with Polycystic Ovary Syndrome

Rudnicka, E., Kunicki, M., Suchta, K., Machura, P., Grymowicz, M., & Smolarczyk, R. (2020) · BioMed Research International · doi:10.1155/2020/4092470 · Cited by 155 · see citing works

Embryotoxic cytokines—Potential roles in embryo loss and fetal programming

Robertson, S. A., Chin, P. Y., Femia, J. G., & Brown, H. M. (2017) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2017.12.003 · Cited by 147 · see citing works

Evaluation of pro-oxidant-antioxidant balance (PAB) and its association with inflammatory cytokines in polycystic ovary syndrome (PCOS)

Artimani, T., Karimi, J., Mehdizadeh, M., Yavangi, M., Khanlarzadeh, E., Ghorbani, M., Asadi, S., & Kheiripour, N. (2017) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1371691 · Cited by 139 · see citing works

Resveratrol treatment in patients with polycystic ovary syndrome decreased pro-inflammatory and endoplasmic reticulum stress markers

Brenjian, S., Moini, A., Yamini, N., Kashani, L., Faridmojtahedi, M., Bahramrezaie, M., Khodarahmian, M., & Amidi, F. (2020) · American Journal of Reproductive Immunology · doi:10.1111/aji.13186 · Cited by 128 · see citing works

The Genetics of Polycystic Ovary Syndrome: An Overview of Candidate Gene Systematic Reviews and Genome-Wide Association Studies

Hiam, D., Moreno‐Asso, A., Teede, H. J., Laven, J. S. E., Stepto, N. K., Moran, L., & Gibson‐Helm, M. E. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101606 · Cited by 126 · see citing works

Polycystic Ovary Syndrome: A Disorder of Reproductive Age, Its Pathogenesis, and a Discussion on the Emerging Role of Herbal Remedies

Zeng, L., Rana, S., Hussain, L., Asif, M., Mehmood, M. H., Imran, I., Younas, A., Mahdy, A., Al‐Joufi, F. A., & Abed, S. N. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.874914 · Cited by 115 · see citing works

Insulin resistance improvement by cinnamon powder in polycystic ovary syndrome: A randomized double‐blind placebo controlled clinical trial

Hajimonfarednejad, M., Nimrouzi, M., Heydari, M., Zarshenas, M. M., Raee, M. J., & Jahromi, B. N. (2017) · Phytotherapy Research · doi:10.1002/ptr.5970 · Cited by 114 · see citing works

Systems Genetics Reveals the Functional Context of PCOS Loci and Identifies Genetic and Molecular Mechanisms of Disease Heterogeneity

Jones, M. R., Brower, M. A., Xu, N., Cui, J., Mengesha, E., Chen, Y. I., Taylor, K. D., Azziz, R., & Goodarzi, M. O. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005455 · Cited by 111 · see citing works

Effects of Melatonin and/or Magnesium Supplementation on Biomarkers of Inflammation and Oxidative Stress in Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial

Mousavi, R., Alizadeh, M., Jafarabadi, M. A., Heidari, L., Nikbakht, R., Babaahmadi‐Rezaei, H., & Karandish, M. (2021) · Biological Trace Element Research · doi:10.1007/s12011-021-02725-y · Cited by 108 · see citing works

Impact of Increased Oxidative Stress on Cardiovascular Diseases in Women With Polycystic Ovary Syndrome

Duică, F., Dănilă, C. A., Boboc, A. E., Antoniadis, P., Condrat, C. E., Onciul, S., Suciu, N., Creţoiu, S. M., Varlas, V. N., & Crețoiu, D. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.614679 · Cited by 106 · see citing works

The inflammatory markers in polycystic ovary syndrome: association with obesity and IVF outcomes

Çakıroğlu, Y., Vural, F., & Vural, B. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0446-4 · Cited by 101 · see citing works

Chronic low-grade inflammation in polycystic ovary syndrome: is there a (patho)-physiological role for interleukin-1?

Popovic, M., Sartorius, G. A., & Christ‐Crain, M. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-019-00737-4 · Cited by 92 · see citing works

Serum levels of TSP ‐1, NF ‐κB and TGF ‐β1 in polycystic ovarian syndrome ( PCOS ) patients in northern China suggest PCOS is associated with chronic inflammation

Liu, M., Gao, J., Zhang, Y., Li, P., Wang, H., Ren, X., & Li, C. (2015) · Clinical Endocrinology · doi:10.1111/cen.12951 · Cited by 89 · see citing works

The effects of synbiotic supplementation on hormonal status, biomarkers of inflammation and oxidative stress in subjects with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial

Nasri, K., Jamilian, M., Rahmani, E., Bahmani, F., Ebrahimi, M. T., & Asemi, Z. (2018) · BMC Endocrine Disorders · doi:10.1186/s12902-018-0248-0 · Cited by 87 · see citing works

Nanocurcumin alleviates insulin resistance and pancreatic deficits in polycystic ovary syndrome rats: Insights on PI3K/AkT/mTOR and TNF-α modulations

AbuelEzz, N. Z., Shabana, M. E.-A., Abdel-Mageed, H. M., Rashed, L. A., & Morcos, G. N. B. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118003 · Cited by 92 · see citing works

Proinflammatory environment and role of TNF-α in endometrial function of obese women having polycystic ovarian syndrome

Oróstica, L., Astorga, I., Plaza-Parrochia, F., Vera, C., Pérez‐García, V. M., Carvajal, R., Gabler, F., Romero, C., & Vega, M. (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.154 · Cited by 87 · see citing works

Low-Grade Chronic Inflammation in Pregnant Women With Polycystic Ovary Syndrome: A Prospective Controlled Clinical Study

Palomba, S., Falbo, A. I., Chiossi, G., Orio, F., Tolino, A., Colao, A., Sala, G. B. L., & Zullo, F. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1214 · Cited by 83 · see citing works

Polycystic ovary syndrome is a risk factor for diabetes and prediabetes in middle-aged but not elderly women: a long-term population-based follow-up study

Kazemi Jaliseh, H., Ramezani Tehrani, F., Behboudi-Gandevani, S., Hosseinpanah, F., Khalili, D., Cheraghi, L., & Azizi, F. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.09.004 · Cited by 80 · see citing works

High throughput circRNAs sequencing profile of follicle fluid exosomes of polycystic ovary syndrome patients

Wang, L., Peng, X., Lv, X., Liu, L., Li, X., He, X., Lv, F., Pan, Y., Wang, L., Liu, K., et al. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28201 · Cited by 78 · see citing works

The Stemness of Human Ovarian Granulosa Cells and the Role of Resveratrol in the Differentiation of MSCs—A Review Based on Cellular and Molecular Knowledge

Józkowiak, M., Hutchings, G., Jankowski, M., Kulcenty, K. I., Mozdziak, P. E., Kempisty, B., Spaczyński, R., & Piotrowska‐Kempisty, H. (2020) · Cells · doi:10.3390/cells9061418 · Cited by 76 · see citing works

The Effects of Magnesium and Zinc Co-Supplementation on Biomarkers of Inflammation and Oxidative Stress, and Gene Expression Related to Inflammation in Polycystic Ovary Syndrome: a Randomized Controlled Clinical Trial

Ebrahimi, F. A., Foroozanfard, F., Aghadavod, E., Bahmani, F., & Asemi, Z. (2017) · Biological Trace Element Research · doi:10.1007/s12011-017-1198-5 · Cited by 76 · see citing works

Differential Expression Profile of Immunological Cytokines in Local Ovary in Patients with Polycystic Ovarian Syndrome: analysis by Flow Cytometry

Qin, L., Xu, W., Li, X.-H., Meng, W., Hu, L., Luo, Z., Wang, Y., Luo, S., & Li, S. (2015) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2015.12.003 · Cited by 75 · see citing works

Modulation of the Inflammatory Response in Polycystic Ovary Syndrome (PCOS)—Searching for Epigenetic Factors

Szukiewicz, D., Trojanowski, S., Kociszewska, A., & Szewczyk, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314663 · Cited by 79 · see citing works

Therapeutic Effects of Silibinin Against Polycystic Ovary Syndrome Induced by Letrozole in Rats via Its Potential Anti-Inflammatory and Anti-Oxidant Activities

Marouf, B. H., Dana, O. I., Hassan, A. H., & Ali, O. J. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s379725 · Cited by 71 · see citing works

Decreased Cholesterol Efflux Capacity and Atherogenic Lipid Profile in Young Women With PCOS

Roe, A. H., Hillman, J., Butts, S. F., Smith, M. P., Rader, D. J., Playford, M. P., Mehta, N. N., & Dokras, A. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3918 · Cited by 69 · see citing works

Effect of Nutritional Supplementation on Oxidative Stress and Hormonal and Lipid Profiles in PCOS-Affected Females

Dubey, P., Reddy, S., Boyd, S., Bracamontes, C., Sanchez, S. S., Chattopadhyay, M., & Dwivedi, A. K. (2021) · Nutrients · doi:10.3390/nu13092938 · Cited by 73 · see citing works

Exercise and Polycystic Ovary Syndrome

Woodward, A., Klonizakis, M., & Broom, D. R. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-1792-1_8 · Cited by 64 · see citing works

Comparison of myo-inositol and metformin on glycemic control, lipid profiles, and gene expression related to insulin and lipid metabolism in women with polycystic ovary syndrome: a randomized controlled clinical trial

Shokrpour, M., Foroozanfard, F., Afshar Ebrahimi, F., Vahedpoor, Z., Aghadavod, E., Ghaderi, A., & Asemi, Z. (2019) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1540570 · Cited by 63 · see citing works

Therapy with probiotics and synbiotics for polycystic ovarian syndrome: a systematic review and meta-analysis

Cozzolino, M., Vitagliano, A., Pellegrini, L., Chiurazzi, M., Andriasani, A., Ambrosini, G., & Garrido, N. (2020) · European Journal of Nutrition · doi:10.1007/s00394-020-02233-0 · Cited by 63 · see citing works

Pro-Inflammatory Markers Negatively Regulate IRS1 in Endometrial Cells and Endometrium from Women with Obesity and PCOS

Oróstica, L., Poblete, C., Romero, C., & Vega, M. (2020) · Reproductive Sciences · doi:10.1007/s43032-019-00026-3 · Cited by 62 · see citing works

The effect of synbiotics pomegranate juice on cardiovascular risk factors in PCOS patients: a randomized, triple-blinded, controlled trial

Esmaeilinezhad, Z., Barati‐Boldaji, R., Brett, N. R., de Zepetnek, J. O. T., Bellissimo, N., Babajafari, S., & Sohrabi, Z. (2019) · Journal of Endocrinological Investigation · doi:10.1007/s40618-019-01139-x · Cited by 61 · see citing works

Current and experimental drug therapy for the treatment of polycystic ovarian syndrome

Corte, L. D., Foreste, V., Barra, F., Gustavino, C., Alessandri, F., Centurioni, M. G., Ferrero, S., Bifulco, G., & Giampaolino, P. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2020.1781815 · Cited by 58 · see citing works

Obesity and insulin resistance in children

Tagi, V. M., & Chiarelli, F. (2020) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000913 · Cited by 56 · see citing works

Inflammatory perspectives of polycystic ovary syndrome: role of specific mediators and markers

Dey, R., Bhattacharya, K., Basak, A. K., Paul, N., Bandyopadhyay, R., Chaudhuri, G. R., Purkait, M. P., Bhattacharjee, A., Bose, C., Shukla, N., et al. (2023) · Middle East Fertility Society Journal · doi:10.1186/s43043-023-00158-2 · Cited by 55 · see citing works

MECHANISMS IN ENDOCRINOLOGY: Nutrition as a mediator of oxidative stress in metabolic and reproductive disorders in women

Diamanti‐Kandarakis, E., Papalou, O., Kandaraki, E., & Kassi, G. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0616 · Cited by 55 · see citing works

Cell and molecular mechanisms behind diet‐induced hypothalamic inflammation and obesity

Ávalos, Y., Kerr, B., Maliqueo, M. A., & Dorfman, M. D. (2018) · Journal of Neuroendocrinology · doi:10.1111/jne.12598 · Cited by 53 · see citing works

Follicular expression of pro-inflammatory cytokines tumour necrosis factor-α (TNFα), interleukin 6 (IL6) and their receptors in cattle: TNFα, IL6 and macrophages suppress thecal androgen production in vitro

Samir, M., Glister, C., Mattar, D., Laird, M., & Knight, P. G. (2017) · Reproduction · doi:10.1530/rep-17-0053 · Cited by 53 · see citing works

Treatment with Metformin and Combination of Metformin Plus Pioglitazone on Serum Levels of IL-6 and IL-8 in Polycystic Ovary Syndrome: A Randomized Clinical Trial

Ali, D.-E.-S., Shah, M., Ali, A., Malik, M. O., Rehman, F., Badshah, H., Ehtesham, E., & Vitale, S. G. (2019) · Hormone and Metabolic Research · doi:10.1055/a-1018-9606 · Cited by 53 · see citing works

Therapeutic Effects and Mechanisms of Herbal Medicines for Treating Polycystic Ovary Syndrome: A Review

Kwon, C.-Y., Cho, I.-H., & Park, K. S. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01192 · Cited by 52 · see citing works

Risk of Polycystic Ovary Syndrome in Women Exposed to Fine Air Pollutants and Acidic Gases: A Nationwide Cohort Analysis

Lin, S.-Y., Yang, Y., Chang, C. Y., Lin, C., Hsu, W., Ju, S.-W., Hsu, C. Y., & Kao, C. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16234816 · Cited by 52 · see citing works

Immune Dysfunction in Polycystic Ovary Syndrome

Banerjee, S., Cooney, L. G., & Stanic, A. K. (2023) · ImmunoHorizons · doi:10.4049/immunohorizons.2200033 · Cited by 52 · see citing works

Evaluation of the Pro-inflammatory Cytokine Tumor Necrosis Factor-α in Adolescents with Polycystic Ovary Syndrome

Pawelczak, M., Rosenthal, J. A., Milla, S. S., Liu, Y., & Shah, B. C. (2014) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2014.01.104 · Cited by 52 · see citing works

Serum tumor necrosis factor-α, interleukin-6, monocyte chemotactic protein-1 and paraoxonase-1 profiles in women with endometriosis, pcos, or unexplained infertility

Younis, A. I., Hawkins, K. C., Mahini, H., Butler, W. J., & Garelnabi, M. (2014) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-014-0237-9 · Cited by 53 · see citing works

A Nonrandomized Trial of Progressive Resistance Training Intervention in Women With Polycystic Ovary Syndrome and Its Implications in Telomere Content

Furtado, C. L. M., Ramos, F. K. P., Kogure, G. S., Santana-Lemos, B. A. A., Ferriani, R. A., Calado, R. T., & dos Reis, R. M. (2016) · Reproductive Sciences · doi:10.1177/1933719115611753 · Cited by 51 · see citing works

The Implication of Mechanistic Approaches and the Role of the Microbiome in Polycystic Ovary Syndrome (PCOS): A Review

Mukherjee, A. G., Wanjari, U. R., Kannampuzha, S., Murali, R., Namachivayam, A., Ganesan, R., Dey, A., Babu, A., Renu, K., Vellingiri, B., et al. (2023) · Metabolites · doi:10.3390/metabo13010129 · Cited by 52 · see citing works

Letrozole vs estradiol valerate induced PCOS in rats: glycemic, oxidative and inflammatory status assessment

Daneasa, A. I., Cucolaş, C., Lenghel, L. M., Olteanu, D. E., Orăsan, R., & Filip, G. A. (2016) · Reproduction · doi:10.1530/rep-15-0352 · Cited by 49 · see citing works

Reactive oxygen species in reproduction: harmful, essential or both?

Jamil, M., Debbarh, H., Aboulmaouahib, S., Filali, O. A., Mounaji, K., Zarqaoui, M., Saadani, B., Louanjli, N., & Cadi, R. (2020) · Zygote · doi:10.1017/s0967199420000179 · Cited by 50 · see citing works

Pregnancy outcomes in women with polycystic ovarian syndrome

D’Alterio, M. N., Sigilli, M., Succu, A. G., GHISU, V., Laganà, A. S., Sorrentino, F., Nappi, L., Tinelli, R., & Angioni, S. L. (2021) · Minerva Obstetrics and Gynecology · doi:10.23736/s2724-606x.21.04758-4 · Cited by 49 · see citing works

Reactome from a WikiPathways Perspective

Bohler, A., Wu, G., Kutmon, M., Pradhana, L. A., Coort, S. L., Hanspers, K., Haw, R., Pico, A. R., & Evelo, C. T. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004941 · Cited by 46 · see citing works

Polycystic Ovary Syndrome as a systemic disease with multiple molecular pathways: a narrative review

Carvalho, L. M. L., dos Reis, F. M., Cândido, A. L., Nunes, F. F. C., Ferreira, C. N., & Gomes, K. B. (2018) · Endocrine Regulations · doi:10.2478/enr-2018-0026 · Cited by 46 · see citing works

Comparison of prevalence of periodontal disease in women with polycystic ovary syndrome and healthy controls

Moaddab, A., Rahiminejad, M., Zaryoun, H., Rabiee, S., Moaddab, A., & Khodadoustan, A. (2015) · Dental Research Journal · doi:10.4103/1735-3327.170547 · Cited by 45 · see citing works

Hepatic manifestations of women with polycystic ovary syndrome

Chen, M., & Ho, H. (2016) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2016.03.003 · Cited by 45 · see citing works

Caesalpinia bonduc (L.) Roxb. as a promising source of pharmacological compounds to treat Poly Cystic Ovary Syndrome (PCOS): A review

Kandasamy, V., & Balasundaram, U. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114375 · Cited by 45 · see citing works

Cangfudaotan decoction inhibits mitochondria-dependent apoptosis of granulosa cells in rats with polycystic ovarian syndrome

Jiang, X., Tai, H., Xiao, X.-S., Zhang, S., Cui, S.-C., Qi, S.-B., Hu, D., Zhang, L.-N., Kuang, J., Meng, X., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.962154 · Cited by 42 · see citing works

Altered Circulating Inflammatory Cytokines Are Associated with Anovulatory Polycystic Ovary Syndrome (PCOS) Women Resistant to Clomiphene Citrate Treatment

Wang, L., Qi, H., Baker, P. N., Zhen, Q., Zeng, Q., Shi, R., Tong, C., & Ge, Q. (2017) · Medical Science Monitor · doi:10.12659/msm.901194 · Cited by 42 · see citing works

White blood cells levels and PCOS: direct and indirect relationship with obesity and insulin resistance, but not with hyperandogenemia

Papalou, O., Livadas, S., Karachalios, A., Tolia, N., Kokkoris, P., Tripolitakis, K., & Diamanti‐Kandarakis, E. (2014) · HORMONES · doi:10.14310/horm.2002.1563 · Cited by 42 · see citing works

Association of obesity and overweight with the prevalence of insulin resistance, pre-diabetes and clinical–biochemical characteristics among infertile Mexican women with polycystic ovary syndrome: a cross-sectional study

Reyes-Muñoz, E., Ortega-González, C., Martínez-Cruz, N., Arce-Sánchez, L., Estrada‐Gutiérrez, G., Morán, C., Sánchez-Serrano, A. P., Higareda-Sánchez, R., & la Jara-Díaz, J. F. D. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-012107 · Cited by 41 · see citing works

Metformin induces lipid changes on sphingolipid species and oxidized lipids in polycystic ovary syndrome women

Pradas, I., Rovira‐Llopis, S., Naudí, A., Bañuls, C., Rocha, M., Hernández‐Mijares, A., Pamplona, R., Víctor, V. M., & Jové, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-52263-w · Cited by 41 · see citing works

Cangfudaotan Decoction Alleviates Insulin Resistance and Improves Follicular Development in Rats with Polycystic Ovary Syndrome via IGF-1-PI3K/Akt-Bax/Bcl-2 Pathway

Wang, C., Ding, C., Hua, Z., Chen, C.-Y., & Jia, Y. (2020) · Mediators of Inflammation · doi:10.1155/2020/8865647 · Cited by 40 · see citing works

A landscape analysis of the potential role of polyphenols for the treatment of Polycystic Ovarian Syndrome (PCOS)

Rani, R., Hajam, Y. A., Kumar, R., Bhat, R. A., Rai, S., & Rather, M. A. (2021) · Phytomedicine Plus · doi:10.1016/j.phyplu.2021.100161 · Cited by 43 · see citing works

Telomere Length and Telomerase Activity in Immature Oocytes and Cumulus Cells of Women with Polycystic Ovary Syndrome

Pedroso, D. C. C., Santana, V. P., Donaires, F. S., de Araújo, M. C. P. M., Giorgenon, R. C., Santana, B. A., Pimentel, R. N., Keefe, D. L., Calado, R. T., Ferriani, R. A., et al. (2020) · Reproductive Sciences · doi:10.1007/s43032-019-00120-6 · Cited by 37 · see citing works

From Prediabetes to Type 2 Diabetes Mellitus in Women with Polycystic Ovary Syndrome: Lifestyle and Pharmacological Management

Pani, A., Gironi, I., Di Vieste, G., Mion, E., Bertuzzi, F., & Pintaudi, B. (2020) · International Journal of Endocrinology · doi:10.1155/2020/6276187 · Cited by 38 · see citing works

Assessing C reactive protein/albumin ratio as a new biomarker for polycystic ovary syndrome: a case–control study of women from Bahraini medical clinics

Kalyan, S., Goshtesabi, A., Sarray, S., Joannou, A., & Almawi, W. Y. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-021860 · Cited by 38 · see citing works

Elevated levels of interleukin-18 are associated with several indices of general and visceral adiposity and insulin resistance in women with polycystic ovary syndrome

Kabakchieva, P., Gateva, A., Velikova, T. V., Georgiev, T., Yamanishi, K., Okamura, H., & Kamenov, Z. A. (2022) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000442 · Cited by 37 · see citing works

Polycystic ovary syndrome (PCOS) and oxidative stress

Sengupta, P., Dutta, S., & Hassan, M. F. (2024) · Journal of Integrated Science and Technology · doi:10.62110/sciencein.jist.2024.v12.752 · Cited by 37 · see citing works

The implications of vitamin content in the plasma in reference to the parameters of carbohydrate metabolism and hormone and lipid profiles in PCOS

Szczuko, M., Hawryłkowicz, V., Kikut, J., & Drozd, A. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105570 · Cited by 38 · see citing works

Effect of TNF-α on Molecules Related to the Insulin Action in Endometrial Cells Exposed to Hyperandrogenic and Hyperinsulinic Conditions Characteristics of Polycystic Ovary Syndrome

Oróstica, L., García, P., Vera, C., García, V., Romero, C., & Vega, M. (2017) · Reproductive Sciences · doi:10.1177/1933719117732157 · Cited by 36 · see citing works

The impact of body mass on inflammatory markers and insulin resistance in polycystic ovary syndrome

Santos, A., Soares, N. P., Costa, E. C., de Sá, J. C. F., Azevedo, G. D., & Lemos, T. M. A. M. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2014.976546 · Cited by 36 · see citing works

Current and emerging drug treatment strategies for polycystic ovary syndrome

Helvaci, N., & Yildiz, B. O. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2022.2108702 · Cited by 35 · see citing works

Effects of eight-week high-intensity interval training on some metabolic, hormonal and cardiovascular indices in women with PCOS: a randomized controlled trail

Mohammadi, S., Monazzami, A., & alavimilani, S. (2023) · BMC Sports Science Medicine and Rehabilitation · doi:10.1186/s13102-023-00653-z · Cited by 35 · see citing works

Associations of Menstrual Cycle Regularity and Length With Cardiovascular Diseases: A Prospective Study From UK Biobank

Huang, C., Lin, B., Yuan, Y., Li, K., Xu, B., Zhang, P., Wei, X., Wang, W., Liu, W., Deng, Y., et al. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.029020 · Cited by 35 · see citing works

Obesity and inflammatory biomarkers in women with polycystic ovary syndrome

Shen, S.-H., Shen, S.-Y., Liou, T., Hsu, M.-I., Chang, Y. I., Cheng, C.-Y., Hsu, C.-S., & Tzeng, C. (2015) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2015.06.022 · Cited by 35 · see citing works

Serum adropin levels are reduced in patients with inflammatory bowel diseases

Brnić, D., Martinović, D., Živković, P. M., Tokić, D., Hadjina, I. T., Rušić, D., Vilović, M., Šupe‐Domić, D., Tonkić, A., & Božić, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-66254-9 · Cited by 35 · see citing works

Heavy Metals and Essential Elements in Association with Oxidative Stress in Women with Polycystic Ovary Syndrome—A Systematic Review

Srnovršnik, T., Virant‐Klun, I., & Pinter, B. (2023) · Antioxidants · doi:10.3390/antiox12071398 · Cited by 34 · see citing works

Polycystic Ovary Syndrome, Insulin Resistance, and Cardiovascular Disease

Dubey, P., Reddy, S., Sharma, K., Johnson, S., Hardy, G., & Dwivedi, A. K. (2024) · Current Cardiology Reports · doi:10.1007/s11886-024-02050-5 · Cited by 38 · see citing works

Polycystic ovary syndrome and extremely preterm birth: A nationwide register-based study

Valgeirsdottir, H., Poromaa, I. S., Kallak, T. K., Vanky, E., Akhter, T., Roos, N., Stephansson, O., & Wikström, A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0246743 · Cited by 34 · see citing works

Anti-Inflammatory Dietary Combo in Overweight and Obese Women with Polycystic Ovary Syndrome

Salama, A., Amine, E., Salem, H. E., & Abd El Fattah, N. (2015) · North American Journal of Medical Sciences · doi:10.4103/1947-2714.161246 · Cited by 33 · see citing works

Biogenesis and functions of circular RNAs and their role in diseases of the female reproductive system

Ma, Y., Xu, Y., Zhang, J., & Zheng, L. (2020) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-020-00653-5 · Cited by 33 · see citing works

Association of IL-1β, IL-1Ra and FABP1 gene polymorphisms with the metabolic features of polycystic ovary syndrome

Rashid, N., Nigam, A., Saxena, P., Jain, S., & Wajid, S. (2017) · Inflammation Research · doi:10.1007/s00011-017-1045-3 · Cited by 31 · see citing works

Expression of Concern: Comparison of myo‐inositol and metformin on clinical, metabolic and genetic parameters in polycystic ovary syndrome: A randomized controlled clinical trial

Jamilian, M., Farhat, P., Foroozanfard, F., Ebrahimi, F. A., Aghadavod, E., Bahmani, F., Badehnoosh, B., Jamilian, H., & Asemi, Z. (2017) · Clinical Endocrinology · doi:10.1111/cen.13366 · Cited by 31 · see citing works

Role of inflammatory markers in polycystic ovaries syndrome: In relation to insulin resistance

Alissa, E. M., Algarni, S. A., Khaffji, A. J., & Mansouri, N. M. A. (2021) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.14684 · Cited by 31 · see citing works

Microbial composition across body sites in polycystic ovary syndrome: a systematic review and meta-analysis

Sola‐Leyva, A., Pérez‐Prieto, I., Molina, N. M., Vargas, E., Ruíz-Durán, S., Leonés-Baños, I., Canha-Gouveia, A., & Altmäe, S. (2023) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2023.03.016 · Cited by 34 · see citing works

Potentials of curcumin against polycystic ovary syndrome: Pharmacological insights and therapeutic promises

Akter, T., Zahan, M. S., Nawal, N. N. A., Rahman, M. H., Tanjum, T. N., Arafat, K. I., Moni, A., Islam, M. N., & Uddin, M. J. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e16957 · Cited by 31 · see citing works

Chronic Low Grade Inflammation in Pathogenesis of PCOS

Rudnicka, E., Suchta, K., Grymowicz, M., Calik-Ksepka, A., Smolarczyk, K., Duszewska, A. M., Smolarczyk, R., & Meczekalski, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073789 · Cited by 680 · see citing works

PCOS AND INFLAMMATION

TAŞCI, A. E. (2023) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.10054852

Pathophysiological roles of chronic low‐grade inflammation mediators in polycystic ovary syndrome

Rostamtabar, M., Esmaeilzadeh, S., Tourani, M., Rahmani, A., Baee, M., Shirafkan, F., Saleki, K., Mirzababayi, S. S., Ebrahimpour, S., & Nouri, H. R. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29912 · Cited by 268 · see citing works

Recent Research on Low Grade Chonic Inflammation in Polycystic Ovary Symdrome

Peng-peng, Q. (2011) · China Modern Doctor

Systemic and ovarian inflammation in women with polycystic ovary syndrome

Zhai, Y., & Pang, Y. (2022) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2022.103628 · Cited by 123 · see citing works